Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan.

MLA

Wei-Chun Chen, et al. “Outcomes and Prognoses of Patients with Ovarian Cancer Using Bevacizumab: 6-Year Experience in a Tertiary Care Hospital of Northern Taiwan.” PLoS ONE, vol. 12, no. 5, Jan. 2017, p. e0175703. EBSCOhost, https://doi.org/10.1371/journal.pone.0175703.

APA

Wei-Chun Chen, Jiantai Timothy Qiu, Chyong-Huey Lai, Huei-Jean Huang, Cheng-Tao Lin, Min-Yu Chen, Hung-Hsueh Chou, Kuan-Gen Huang, & Ting-Chang Chang. (2017). Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan. PLoS ONE, 12(5), e0175703. https://doi.org/10.1371/journal.pone.0175703

Chicago

Wei-Chun Chen, Jiantai Timothy Qiu, Chyong-Huey Lai, Huei-Jean Huang, Cheng-Tao Lin, Min-Yu Chen, Hung-Hsueh Chou, Kuan-Gen Huang, and Ting-Chang Chang. 2017. “Outcomes and Prognoses of Patients with Ovarian Cancer Using Bevacizumab: 6-Year Experience in a Tertiary Care Hospital of Northern Taiwan.” PLoS ONE 12 (5): e0175703. doi:10.1371/journal.pone.0175703.